SANUWAVE Health, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +41.2% | -17.3% | +23.8% | +30.7% | +10.3% | -9.5% | +8.8% | +12.7% | +14.3% | -26.5% | +1.2% | – | |
| – | +66.3% | -32.5% | +21.3% | +19.3% | -0.3% | -14.3% | +12.7% | +24.6% | +23.4% | -28.2% | -4.9% | – | |
| – | +31.2% | -9.6% | +24.7% | +34.9% | +13.8% | -8.2% | +7.8% | +9.4% | +11.5% | -25.9% | +3.3% | – | |
| – | -13.3% | +14.0% | +19.6% | -17.4% | -4.3% | +35.1% | -6.7% | +77.8% | +75.7% | +8.9% | -4.8% | – | |
| – | -25.6% | +84.1% | -50.0% | +38.4% | +29.2% | +35.8% | -9.6% | +19.1% | +25.9% | -13.3% | -6.6% | – | |
| – | -11.4% | +45.6% | -38.2% | +57.5% | +7.9% | +15.9% | -5.0% | +19.0% | +25.6% | -8.6% | -7.3% | – | |
| – | – | -201.1% | – | -2.0% | +29.1% | -60.9% | +90.4% | -21.8% | -58.1% | -282.8% | – | – | |
| – | -18.9% | +14.1% | +6.3% | -3.2% | -28.1% | -29.7% | +1.2% | -8.1% | -53.7% | -31.6% | -5.1% | – | |
| – | – | -124.8% | – | -414.8% | – | – | – | +878.7% | -40.0% | -123.2% | – | – | |
| – | -98.2% | +3,368.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -124.8% | – | -414.8% | – | – | – | +878.7% | -40.8% | -123.6% | – | – | |
| – | – | -103.5% | – | -257.8% | – | – | – | +283.4% | -38.3% | -107.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.